viewFrontier IP Group PLC

Frontier IP sees maturity spread across portfolio companies


• Investment firm focused on commercialisation of IPs
• Provides services to university and research organisations to brink products to market
• Takes equity stakes in spin-out companies

Investment papers and laptop

Quick facts: Frontier IP Group PLC

Price: 66.6 GBX

Market: AIM
Market Cap: £36.63 m

What Frontier IP does

Frontier IP Group Plc (LON:FIPP) is an investment and asset management company that focuses on providing consultancy services to universities and other research organisations to help them commercialise any intellectual property (IP) arising from their research.

The group aims to grow its value by taking equity stakes in any spin-out companies that arise from the commercialisation of IP.

What it owns

Frontier’s portfolio consists of stakes in

Alusid – Develops SilicaStone, a stone substitute made from recycled industrial waste

Nandi Proteins – Researches technology to improve the functional properties of proteins used in food-making such as eggs and whey

The Vaccine Group – Makes vaccines for animals to prevent them from passing on illnesses to humans such as Ebola, SARS, AIDS, Marburg, and swine and bird flu

Tarsis Technology – Develops tech that allows controlled delivery of active ingredients using metal-organic frameworks

Porexpert – Provides software to help model porous structures and test their properties

Pulsiv Solar – Develops technology to increase energy efficiency in solar farms as well as power converters for TVs, mobile phones and other electronics

Exscientia – Uses artificial intelligence to automate the design of pharmaceutical drugs

Cambridge Simulation Solutions – Provides methods of simulating and controlling complex discontinuous processes, such as how neural transmitters work in the brain

Amprologix – Aims to introduce new classes of antibiotics to help combat antimicrobial resistance to treatments

Molendotech – Provides a rapid assay to screen water for faecal contamination and other harmful bacteria without the need for laboratory testing

Fieldwork Robotics – Develops robot technology to harvest fruits and vegetables

NTPE – Develops a technology to print electronic circuits and semiconductors onto paper

Elute – Software firm specialising in plagiarism detection

AquaInSilico – Software group developing tools for wastewater management

How it's doing

In September, Nandi Proteins raised £720,000 via a convertible loan, including a £360,000 investment from the UK Government's Future Fund.

The commercialising intellectual property specialist said the investment from the Future Fund, established to support innovative businesses through the coronavirus (COVID-19) outbreak, has been matched by £320,000 from the group and £40,000 invested by Shackleton Finance, which specialises in secondary venture and development capital investments.

Inflexion points

  • Elute opened up access to its Patent Reader platform to a user group of experienced patent professionals to help them effectively and efficiently find relevant information
  • Exscientia has recently raised $60mln through a Series C financing round
  • Frontier has become involved in ScienceIN2Business, a technology transfer competition run by the University of Lisbon
  • The Vaccine Group said it is making “significant progress” with its animal vaccine platform and, significantly, has started work on an animal inoculation that would prevent the spread of coronavirus from animal to human

Executive interview

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Frontier IP Group PLC named herein, including the promotion by the Company of Frontier IP Group PLC in any Content on the Site, the Company...


Frontier IP focused on further industrial engagement across portfolio

Neil Crabb, chief executive of Frontier IP Group Plc (LON:FIPP) caught up with Proactive's Andrew Scott following the release of their half-year report. Frontier’s portfolio includes AI drug researcher Exscientia which secured a €15mln strategic investment from drug discovery company...

on 29/3/18

3 min read